Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells. (Q48592496)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2002

Language	Label	Description	Also known as
English	Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.	scientific article published in June 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

tuberous sclerosis

1 reference

based on heuristic

inferred from title

tuberous sclerosis 1

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Stephen P Burke

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

David H. Gutmann

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Erik J Uhlmann

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Anthony J Apicelli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rebecca L Baldwin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Livia Bajenaru

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hiroaki Onda

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

David Kwiatkowski

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

4050-4059

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12037687%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Mitogenic and oncogenic properties of the small G protein Rap1b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

New developments in the neurobiology of the tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Functional analysis of neurofibromatosis 2 (NF2) missense mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Alterations in the rap1 signaling pathway are common in human gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

A cell cycle-regulated inhibitor of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

CNS stem cells express a new class of intermediate filament protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

The TSC1 gene product, hamartin, negatively regulates cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Two loci for tuberous sclerosis: one on 9q34 and one on 16p13.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Expression of Rab GTPases using recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

21 January 2018

Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205435

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48592496&oldid=2209620441"